LIGAND PHARMACEUTICALS INC (LGND)
Pharmaceutical Preparations
Latest Price
$280.65
TTM P/E
29.08
Normalized P/E
157.85
Div Yield
--
Book Value
48.44
P/B Ratio
5.79
Valuation metrics
adjust assumptions →EPS: $6.13
Book value / share: $51.44
Formula: √(22.5 × EPS × BVPS)
Graham Number
$84.23
70% downside
Norm. op. income: $26M (median of 7yr)
Tax rate: 21%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$47.42
83% downside
Base FCF: $70M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$300.69
+7% upside
EPS: $6.13
Target P/E: 29×
Formula: EPS × P/E
P/E Fair Value
$177.77
37% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3.10M | $980.0M | 15.57% | +139.1K | 2026-06-30 |
| Invesco Ltd. | 1.20M | $379.0M | 6.03% | +378.0K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.14M | $359.0M | 5.71% | +38.0K | 2026-06-30 |
| Jupiter Topco LLC | 1.04M | $328.0M | 5.22% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 871.0K | $275.0M | 4.37% | +22.9K | 2026-06-30 |
| STATE STREET CORP | 826.5K | $261.0M | 4.15% | +47.7K | 2026-06-30 |
| FMR LLC | 762.8K | $241.0M | 3.83% | +166.7K | 2026-06-30 |
| FRANKLIN RESOURCES INC | 752.0K | $237.0M | 3.78% | +178.9K | 2026-06-30 |
| CONGRESS ASSET MANAGEMENT CO | 659.9K | $208.0M | 3.31% | +155.3K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 589.0K | $186.0M | 2.96% | +30.1K | 2026-06-30 |